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A B S T R A C T
In this paper we screened the dichloromethane extract from the aerial parts of Salvia 
officinalis L., Lamiaceae, against a representative panel of microorganisms that cause 
caries, conducted a bioassay-guided fractionation to establish themselves the most active 
metabolite (manool) and determined the Salvia officinalis fraction with the manool highest 
concentration to be used to activate an ingredient in oral care products such as toothpastes 
and mouthwashes. Both manool and S. officinalis extract showed very promising minimal 
inhibitory concentration values (between 6.24 and 31.36 μg.ml-1) and time kill curves against 
the primary causative agents of dental caries (Streptococcus mutans) revealed that, at twice its 
minimal bactericidal concentration (12.48 μg.ml-1), manool required 6 h to completely kill the 
bacteria. Salvia officinalis extract at twice its minimal bactericidal concentration (31.36 μg.ml-1) 
needed 12 h. The results achieved with Salvia officinalis extract motivated us to develop and 
validate an analytical RP-HPLC method to detect and determine manool in this extract. 
The validation parameters were satisfactorily met and evaluated allows us to consider the 
developed method suitable for use in different labs. In conclusion, our results evidenced that 
the manool-rich S. officinalis extract can be considered an analytically validated alternative 
to develop novel and effective antimicrobial agents against the main bacteria responsible for 
dental caries.
© 2013 Brazilian Society of Pharmacognosy. Published by 
Elsevier Editora Ltda. 
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Introduction
Despite the modern strategies based on rational drug design 
and combinatory chemistry, phytomedicines and active 
substances isolated from plants remain important sources 
of pharmaceutical products (Calixto, 2000). The emergence of 
a more sophisticated market for these products has pressed 
for regulation and testing, which is a great opportunity for 
biodiversity-rich countries like Brazil (Desmarchelier, 2010; 
Seidl, 2002).
Extracts from different Salvia species have been investigated 
for several biological activities (Akhondzadeh et al., 2003; 
Capasso et al., 2004; Khalil; Li, 2011; Kontogianni et al., 2013; 
Ren et al., 2004). Sage (Salvia officinalis L., Lamiaceae), a 
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herbaceous plant cultivated worldwide, is usually employed 
in flavoring and seasoning food. Its botanical name refers to 
its medicinal properties: Salvia is derived from the Latin word 
“salvare” and means “to cure”; officinalis medicinal means 
(Miura et al., 2002). The antimicrobial potential of this herb 
is well established (Bozin et al., 2007; Delamare et al., 2007; 
Horiuchi et al., 2007a; 2007b) and, a few years ago, a review 
of the literature on the use of medicinal plants to treat dental 
diseases in Brazil pointed out that S. officinalis is one of the 
most employed often species. Therefore, this herb is also a 
potential candidate to devise novel medicines to be applied in 
dentistry (Oliveira et al., 2007).
In recent years, our group has concentrated on the 
antibacterial activity of secondary plant metabolites against 
strains responsible for pathologies like human oral caries, 
periodontitis, and endodontic lesions (Carvalho et al., 2011; De 
Andrade et al., 2011; Porto et al., 2009; Souza et al., 2011a; 2011b). 
Bearing in mind the potential use of S. officinalis in dentistry, in 
this paper we screened the dichloromethane extract from the 
aerial parts of S. officinalis (SOD) against a representative panel 
of microorganisms that cause caries. We conducted a bioassay-
guided fractionation, to establish themselves the most active 
metabolite (manool, MO, 1), and determine the Salvia officinalis 
fraction with the highest MO concentration (labeled SODH2). 
We assessed the in vitro antimicrobial properties of MO and 
SODH2 against the main cariogenic bacteria and developed 
a validated RP-HPLC (Reversed Phase High Efficiency Liquid 
Chromatography) analytical method to detect and quantify MO 
in SODH2 according to the guide RE 899/2003 (Anvisa, 2003).
Plant material, bioguided-assay fractionation and manool 
isolation
Aerial parts (1.0 kg) of Salvia officinalis L., Lamiaceae, were 
purchased at Nutriervas (SP, Brazil). The identification was 
carried out by Prof. Milton Groppo and a voucher specimen (SPFR 
15178) was deposited in the herbarium of the Departamento de 
Biologia, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. 
The plant material was then pulverized, and exhaustively 
extracted with dichloromethane 5 l at room temperature. This 
procedure furnished 45.5 g crude extract (SOD) after solvent 
evaporation. SOD was suspended in 300 ml methanol/H2O 
(9:1) and filtered; the soluble fraction was partitioned with 
n-hexane (400 ml four times) and dichloromethane (400 ml, 
four times), which yielded the n-hexane-soluble (10.6 g) and 
the dichloromethane-soluble (6.7 g) fractions (SODH and SODD, 
respectively). The MIC (Minimal Inhibitory Concentration) values 
of SODH and SODD were determined against S. mutans, the 
primary causative agent of dental caries (Chung et al., 2006). 
Because SODH was the most effective fraction, it was subjected 
to vacuum chromatography over silica gel 60H (500 g; Merck, 
art. 7736) (Pelletier et al., 1986) using n-hexane and ethyl acetate 
increasing amounts of the eluent (1500 ml each fraction). After 
solvent evaporation, this procedure afforded seven fractions 
(SODH1-SODH7), which were also assayed against S. mutans. 
Fraction SODH2 (2.89 g) was the most active antibacterial extract; 
thus, about 2.00 g of this fraction was partitioned by column 
chromatography classic over silica gel 60 (100 g; Merck, art. 7734) 
using n-hexane/ethyl acetate 9:1 as eluent. Fifty fractions were 
collected and further combined into six new fractions (SODH2.1 
to SODH2.6). SODH2.3 (152 mg) was the most active against 
S. mutans. 1H and 13C NMR analyses identified the diterpene 
manool (1) the main constituent of SODH2.3.
Bacterial strains and antimicrobial testing
The MIC and MBC (Minimal Bactericidal Concentration) 
values were determined by the broth microdilution method 
using 96-well microplates, in triplicate (Porto et al., 2009). 
The Streptococcus salivarius strains (ATCC 25975), Streptococcus 
sobrinus (ATCC 33478), Streptococcus mutans (ATCC 25275), 
Streptococcus mitis (ATCC 49456), Streptococcus sanguinis (ATCC 
10556), and Lactobacillus casei (ATCC 11578) were obtained from 
the American Type Culture Collection (ATCC). 
The tested samples (MO and SODH2) were dissolved in 
dimethyl sulfoxide (DMSO; Synth) at 1 mg.ml-1, followed by 
dilution in tryptic soy broth (Difco), which gave the final DMSO 
content of 5% (v/v) and concentrations ranging from 400.00 to 
0.19 mg.ml-1 for MO and from 2000.00 to 0.98 mg.ml-1 for SODH2. 
The inoculum was adjusted for each organism, to yield a cell 
concentration of 5 × 105 colony forming units (CFU) per ml, 
according to the guidelines of the Clinical Laboratory Standards 
Institute (CLSI, 2006). One well was inoculated included, to 
control the adequacy of the broth for organism growth. One 
non-inoculated well, free of antimicrobial agent, was employed 
also, medium to ensure sterility. CHD at concentrations ranging 
from 0.11 to 7.36 mg.ml-1 was used as control positive; DMSO at 
5% (v/v) concentration was the negative control. The microplates 
(96-wells) were sealed with plastic film and incubated at 37°C, 
1
Materials and methods
Reagents and standards
Acetonitrile (chromatographic grade) was supplied by 
Mallinkrodt Baker Inc. (Phillipsburg, NJ, USA). Water was 
purified using Milli-Q-plus filter systems (Millipore, Bedford, 
MA, USA). The internal standard methyl ent-kaur-16(17)-en-19-
oate (IS) was synthesized by diazomethane methylation of ent-
kaur-16(17)-en-19-oic acid isolated from Mikania hirsutissima, 
as previously described (De Andrade et al., 2011). MO and IS 
purity (between 95-98%) was checked by Nuclear Magnetic 
Ressonance. Doxorubicin hydrochloride (purity > 98.0%) and 
chlorhexidine dihydrochloride (purity ≥ 99.5%) were purchased 
from Sigma-Aldrich (St. Lois, MO, USA). 
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for 24 h. After this period, resazurin (30 ml) in aqueous solution 
(0.02%) was added to the microplates, to indicate microorganism 
viability (Porto et al., 2009). Before resazurin was added, an 
aliquot of the inoculum was aseptically removed from each 
well with no apparent microorganism growth and plated onto 
tryptic soy agar supplemented with 5% sheep blood. The plates 
were incubated as described previously, in order to determine 
the MBC. The fractions submitted to the bioguided-assay were 
tested only against S. mutans.
Time-kill curves
Time-kill assays were performed in triplicate, according to the 
procedure described by D’Arrigo et al. (D’Arrigo et al., 2010); 
both MO and SODH2 were tested against S. mutans. Tubes 
containing MO concentrations at the end of 6.24, 12.48, and 
18.72 μg.ml-1 (respectively one, two, and three-times the MBC 
of MO for S. mutans) and 15.68, 31.36, and 47.04 μg.ml-1 (one 
respectively, two, and three-times the MBC of SODH2 for S. 
mutans) were inoculated with the microorganism tested, to give 
an initial bacterial density of 5 × 105 CFU ml-1, and incubated 
at 37°C. To determine microorganism viability, samples were 
removed at 6, 12, and 24 h of incubation, followed by dilution 
in sterile fresh medium, if necessary. The diluted samples 
(50 μl) were spread onto tryptic soy agar plate supplemented 
with 5% sheep blood, incubated at 37°C, and counted after 48 
h. Time-kill curves were constructed by plotting the log10 CFU 
ml versus time. The positive (CHD, at its MBC of 3.69 μg.ml-1) 
and the negative (suspension of S. mutans without added MO 
or SODH2) controls were also assayed in triplicate. 
Cytotoxicity assay
We employed the XTT assay to evaluate the effect of both MO 
and SODH2 on cell viability using the primary human fibroblast 
cell line obtained from Coriell Cell Repositories (New Jersey, 
USA). Cells were trypsinized and seeded in a 96-well plate 
at a concentration of 104 cells/well in DEMEM plus HAM-F10 
(1:1, v/v) medium (Sigma, St. Louis, USA) supplemented with 
20% fetal bovine serum (Life Technologies, California, USA). 
After 24 h of incubation at 37ºC, cell cultures were treated for 
further 24 h with different concentrations of MO or SODH2 (7.8 
to 500.0 μM) dissolved in DMSO (1%). Cell viability was assessed 
with the Cell Proliferation Kit II (Roche, Mannhein, Germany), 
according to the manufacturer’s instruction. Absorbance of 
the orange formazan product was read at 490 nm, reference 
wavelength at 620 nm, in a microplate reader Sunrise (Tecam, 
Männdorf, Switzerland). Cell viability is expressed as the 
percentage of the viability achieved with the negative control. 
Doxorubicin at 3.0 μg.ml-1 was used as positive control.
RP-HPLC method development and validation
The LC (Liquid Chromatograph) consisted of a two-pump 
system Liquid Chromatography Shimadzu model LC-20A 
Prominence equipped with a SIL-20A auto sampler, a CTO-
20A column oven, a CBM-20A communications bus module, an 
in-line degasser DGU-20A3, and a photodiode array detector 
(SPD-M20A). The LC solution software (version 1.25) was used 
for data processing. Analyses were conducted on a Shim-pack 
CLC-ODS column (25 cm × 4.6 mm i.d, 5 μm; Shimadzu).
To estimate the optimal conditions to develop the method, 
preliminary experiments were conducted using the gradient 
scouting run evaluation described by Snyder and Dolan (Snyder 
and Dolan, 1996). After the final adjustments, the optimized 
conditions included an isocratic elution system consisting of 
90% acetonitrile in water and 0.1% acetic acid (v/v), at a flow 
rate of 1.0 ml.min-1. The temperature of the column was set at 
40°C; absorbance was read at 201 nm.
Preparation of sample solutions 
The sample solutions were prepared by dissolving 4.82 mg of 
SODH2 and 0.75 mg of methyl ent-kaurenoate (IS) in 5 ml of 
acetonitrile, followed by filtration through a UNIFLO 25/0,2 PTFE 
syringe filter (Whatman/Schleicher & Schuell, Maidstone, UK).
Selectivity 
Spectral purity of the MO peak obtained for all the samples 
was evaluated by DAD spectral data recorded in the ascending, 
upper, and descending regions; their respective regions were 
compared with the MO obtained peaks in the calibration curve. 
All the spectra matched perfectly, confirming that no other 
compounds co-eluted with MO.
Linearity 
Standard MO solutions (500.0, 400.0, 300.0, 200.0, 100.0, 80.0, 
40.0, and 20.0 μg.ml-1) were prepared in acetonitrile; 20-μl 
aliquots of these solutions were injected into the HPLC 
equipment, in triplicate. The data were used to construct the 
calibration curve for MO concentration and were submitted to 
regression analysis. The correlation coefficient was calculated 
using Microsoft Excel®.
Limits of detection (LOD) and quantification (LOQ)
LOD and LOQ values were determined on the basis of the 
standard deviation of the response (V) and of the slope of the 
calibration curve (S), using the expressions LOD = 3.3V/S and 
LOQ = 10V/S.
Precision
The intraday precision was evaluated by analyzing six samples; 
the interday precision was assayed on two consecutive 
days. The concentration of MO in SODH2 was determined, 
to calculate the relative standard deviation (RSD). For the 
interday precision, the mean values of MO were concentrations 
compared by t test (p < 0.05) using GraphPad Prism®.
Accuracy
The accuracy of the method was determined by spiking known 
contents of MO into the SODH2 at low, medium, and high levels 
(respectively 25, 50, and 100% of the MO content determined 
for SODH2), in triplicate. Then, solutions were prepared as 
described previously and analyzed (Ribani et al., 2004).
Robustness
The robustness of the chromatographic method was assessed 
following the experimental design proposed by Plackett-
Burman and described by Vander Heyden et al.( 2001). Briefly, 
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the operational factors related to the chromatographic method-
mobile phase flow rate, column oven temperature, percentage 
of organic solvent (%B) in the mobile phase, detection 
wavelength, and volume of sample injected (Table 1) were 
selected. Next, variation levels for each of these operational 
factors (Table 1) were determined using the method described 
in “Materials and Methods” at the beginning of the subsection 
“RP-HPLC method development and validation”. These levels 
were either represented the level (−1), when the factors were 
in the negative limit, or level (+1), when the above factors 
were the positive limit; these levels were divided into eight 
experiments, the shown in the Plackett–Burman design 
(Vander Heyden et al., 2001) (Table 2). Two dummy factors had 
to be included, to reach a saturated design. Each experiment 
was carried out for the pre-determined limit of −1 and +1 each 
factor variation. The response y was obtained at the end of 
each experiment (Table 2).
The responses selected for this study were the peak area 
and relative retention time (rrt) of the target component 
detected in SODH2 (MO). On the basis of the eight responses 
and considering the responses selected, the estimated effect 
was calculated for each factor using the equation following:
 
where E is the estimated effect of the selected response x; x is 
the peak area or rrt of MO; ∑y(+) is the sum of positive responses 
at level; ∑y(−) is the sum of responses at thenegative level; N is 
the number of experiments. To improve the interpretation of 
the results from the robustness study, the effect estimated Ex 
was converted using the equation RSD % = (S/X)·100, in which 
RSD % is the relative standard deviation, S is the value of Ex, 
and X represents the mean of the responses of y, considering 
the different responses and factors.
Results and discussion
Analysis of Table 3 reveals lower MIC values for MO as 
compared with SODH2 for all the tested bacteria, which was 
expected. According to some authors (Gibbons, 2008; Rios and 
Recio, 2005), extracts like SODH2 are promising in the search 
of new anti-infection agents at much higher concentrations 
(up to 100 μg.ml-1) than required for pure those metabolites 
such as MO (up to 10 μg.ml-1). Therefore, our results attest to 
the importance of both plant-derived MO and SODH2 in the 
search for new effective antimicrobial agents. 
Antimicrobial compounds have different action 
mechanisms demonstrated (Greenberg et al., 2008). Several 
authors have emphasized that diterpenes are an important 
class of plant metabolites for the search of new antibacterial 
agents; however, the mechanism(s) responsible for this 
property have not yet been very well elucidated (Urzúa et al., 
2008). Urzúa et al. (2008) have suggested that these metabolites 
Factors Abbreviation Units Limits
Level
(-1)
Level
(+1)
Nominal
Mobile 
phase flow 
rate
Flow ml.min-1 ± 0.1 0.9 1.1 1.0
Column 
oven 
temperature
Temp. °C ± 5 35 45 40
Percentage 
of organic 
solvent 
(%B) in the 
mobile 
phase
%B % ± 1 89 91 90
Detector 
wavelength
O nm ± 5 196 206 201
Volume of 
injected 
sample
Inj. μl ± 1 19 21 20
Table 1
Factors and levels investigated in the robustness test.
Experiment
number
Factors
Response
A B C D E F G
Flow Temp Dummy 
1
%B O Inj. 
vol.
Dummy 
2
1 +1 +1 +1 -1 +1 -1 -1 y1
2 -1 +1 +1 +1 -1 +1 -1 y2
3 -1 -1 +1 +1 +1 -1 +1 y3
4 +1 -1 -1 +1 +1 +1 -1 y4
5 -1 +1 -1 -1 +1 +1 +1 y5
6 +1 -1 +1 -1 -1 +1 +1 y6
7 +1 +1 -1 +1 -1 -1 +1 y7
8 -1 -1 -1 -1 -1 -1 -1 y8
Table 2
Plackett–Burman design for seven factors and eight 
experiments (Vander Heyden et al., 2001).
Bacteria (ATCC)
MIC (MBC) in μg.ml-1
CHDa MO SODH2
S. mutans (25275) 0.92 (3.69) 6.24 (6.24) 15.68 (15.68)
S. salivarius (25975) 0.92 (0.92) 24.96 (49.92) 31.36 (31.36)
S. sanguinis (10556) 3.69 (3.69) 12.48 (12.48) 15.68 (15.68)
S. sobrinus (33478) 0.92 (0.92) 24.96 (24.96) 31.36 (31.36)
S. mitis (49456) 3.69 (3.69) 12.48 (12.48) 15.68 (15.68)
L. casei (11578) 0.92 (0.92) 12.48 (12.48) 31.36 (62.72)
aChlorhexidine dihydrochloride, positive control. 
5% DMSO solution, Negative control did not affect the growth of the 
microorganisms.
Table 3
In vitro antibacterial activity (MIC and MBC) of manool (MO) 
and MO-rich extract (SODH2) against oral pathogens.
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promote bacterial lysis and disruption of the cell membrane. 
According to these authors, the structural features that 
promote the efficient antibacterial activity include a lipophilic 
structure, capable of insertion into the cell membrane, and 
one strategically positioned hydrogen-bond-donor group (HBD; 
hydrophilic group), which interacts with the phosphorylated 
groups on the membrane. A careful observation of the results 
depicted in Table 3 reveals that MO, which contains the structural 
requirements proposed by Urzúa et al., display very promising 
MIC values (Gibbons, 2008, Rios and Recio, 2005). Based on 
these considerations, our results give support to the suggested 
mechanism of action (Urzúa et al., 2008).
To better understand the observed antimicrobial activity, we 
conducted time-kill studies of MO and SODH2 using MBC their 
respective values; we determined how long MO and SODH2 
took to completely kill S. mutans, one of the primary causative 
agents of dental caries. Fig. 1 shows that CHD (positive control) 
was able to completely kill the S. mutans inoculum at the 
lowest MBC (3.69 μg.ml-1) after 24 h. At 12.48 μg.ml-1 (twice its 
MBC value), MO required 6 h to completely kill the bacteria; 
SODH2 at twice its MBC (31.36 μg.ml-1) needed 12 h. These 
results are remarkable, considering the short period relatively 
that the active ingredients of oral care products remain in the 
oral cavity. In addition, neither MO nor SODH2 were cytotoxic 
to the human fibroblast cell line tested at the concentrations. 
Therefore, MO and SODH2 are important and selective plant-
Figure 1 - Time-kill curves obtained for manool (A) and 
SODH2 (B) against Streptococcus mutans using CHD and 
5% DMSO solution as positive and negative controls, 
respectively.
Figure 2 - Typical SODH2 chromatogram obtained at 
established conditions (isocratic elution system of 90% 
acetonitrile in water with 0.1% acetic acid at a flow rate of 
1.0 ml.min-1, column temperature of 40°C, and detection at 
201 nm). Insert: UV spectrum of MO.
derived products with potential application in the control of 
caries disease.
Considering the increasing importance of plant-derived 
extracts in the global pharmaceutical market (Desmarchelier, 
2010; Seidl, 2002), the results achieved with SODH2 motivated 
us to develop and validate an analytical RP-HPLC method 
to detect and determine MO in this extract. Fig. 2 illustrates 
a typical chromatogram of SODH2; the UV spectral purity 
confirmed the selectivity of the method.
We calculated the linearity of the plot concentration vs peak 
area for MO and obtained a correlation coefficient (r2) of 0.9971 
(Table 4). The linear regression equation was:
where y is the detector response (in absorbance units) and 
x is the MO concentration (in μg.ml-1). As mentioned before, 
the LOD and the LOQ values were calculated on the basis of 
the response (V = 1111.778) and of the slope of the calibration 
curve (S = 29119.333) and corroborated the sensitivity of the 
developed method (Table 4).
We determined the intraday precision of the method by 
analyzing the chemical marker (MO) in six SODH2 samples; 
we assayed the interday precision on two consecutive days. 
All the RSD values for MO concentrations were less than 
5%, and the means obtained on different days did not differ 
statistically (p < 0.05) (Table 4). To determine the accuracy 
of the method and after the addition of known contents of 
MO (25, 50 and 100%), the RSD values for all concentrations 
obtained, in triplicate, (Table 4) were also less than 5%, 
indicating that the results were adequate for the purposes 
analytical of the developed method (Anvisa, 2003).
The robustness test examines sources that potentially 
are subject to variations when one or a set of responses 
inherent to the method is being evaluated. To examine these 
sources, it is necessary to insert a number of factors into 
the validation procedure and deliberate on selected and 
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Parameters rrta rrt RSDb (%) Ex on rrt RSD (%) Concentration (μg.ml
-1) Concentration RSD (%) RSD (%)
LOQ 0.382
LOD 0.126
Precision
Intraday 0.594 0.008 174.362 0.067
Interday 0.594 0.010 174.028 0.217
Accuracy
Low 0.593 0.009 212.737 0.018
Medium 0.593 0.019 254.138 0.032
High 0.593 0.021 333.639 0.046
Robustness
Flow 0.116 -19.621
Temp. -4.353 2.134
%B -2.511 4.306
O -0.010 -50.590
Inj. -0.038 10.289
aRelative retention time calculated using the IS. 
bRelative standard deviation.
Table 4
Analytical parameters of LOD, LOQ, precision, accuracy, and robustness obtained for the developed method.
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